retatrutide dosing human trials VisualAbstract: reduces body weight by 17.5% in patients with obesity retatrutide clinical trial dosing frequency

GLP-1 agonists have demonstrated anti-inflammatory effects in the central nervous system, potentially breaking this feedback loop

If long-term results hold up, it may become a standard of care for menopause-related weight gain

You receive pharmaceutical-grade GLP-1 medication, complete injection training (it's easy!), nutritional guidance appropriate to your tier, and follow-up scheduling

Useful for catching imbalances that can worsen with vomiting or diarrhea early in treatment

This careful, professional evaluation ensures that Wegovy or Zepbound is a safe and appropriate choice for you

Citti C, Russo F, Sgr S, Gallo A, Zanotto A, Forni F, et al